Abstract
The severe mental retardation and speech deficits associated with 22q13 terminal deletions have been attributed in large part to haploinsufficiency of SHANK3, which maps to all 22q13 terminal deletions, although more proximal genes are assumed to have minor effects. We report two children with interstitial deletions of 22q13 and two copies of SHANK3, but clinical features similar to the terminal 22q13 deletion syndrome, including mental retardation and severe speech delay. Both these interstitial deletions are completely contained within the largest terminal deletion, but do not overlap with the nine smallest terminal deletions. These interstitial deletions indicate that haploinsufficiency for 22q13 genes other than SHANK3 can have major effects on cognitive and language development. However, the relatively mild speech problems and normal cognitive abilities of a parent who transmitted her identical interstitial deletion to her more severely affected son suggests that the phenotype associated with this region may be more variable than terminal deletions and therefore contribute to the relative lack of correlation between clinical severity and size of terminal deletions. The phenotypic similarity between the interstitial deletions and non-overlapping small terminal 22q13 deletions emphasizes the general nonspecificity of the clinical picture of the 22q13 deletion syndrome and the importance of molecular analysis for diagnosis.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Koolen DA, Reardon W, Rosser EM et al: Molecular characterisation of patients with subtelomeric 22q abnormalities using chromosome specific array-based comparative genomic hybridisation. Eur J Hum Genet 2005; 13: 1019–1024.
Lindquist SG, Kirchhoff M, Lundsteen C et al: Further delineation of the 22q13 deletion syndrome. Clin Dysmorphol 2005; 14: 55–60.
Luciani JJ, de Mas P, Depetris D et al: Telomeric 22q13 deletions resulting from rings, simple deletions, and translocations: cytogenetic, molecular, and clinical analyses of 32 new observations. J Med Genet 2003; 40: 690–696.
Manning MA, Cassidy SB, Clericuzio C et al: Terminal 22q deletion syndrome: a newly recognized cause of speech and language disability in the autism spectrum. Pediatrics 2004; 114: 451–457.
Phelan MC, Rogers RC, Saul RA et al: 22q13 deletion syndrome. Am J Med Genet 2001; 101: 91–99.
Wilson HL, Wong ACC, Shaw SR et al: Molecular characterization of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms. J Med Genet 2003; 40: 575–584.
Havens JM, Visootsak J, Phelan MC, Graham Jr JM : 22q13 deletion syndrome: an update and review for the primary pediatrician. Clin pediatr 2004; 43: 43–53.
Anderlid BM, Schoumans J, Anneren G et al: FISH-mapping of a 100-kb terminal 22q13 deletion. Hum Genet 2002; 110: 439–443.
Bonaglia MC, Giorda R, Mani E et al: Identification of a recurrent breakpoint within the SHANK3 gene in the 22q13.3 deletion syndrome. J Med Genet 2006; 43: 822–828.
Wong AC, Ning Y, Flint J et al: Molecular characterization of a 130-kb terminal microdeletion at 22q in a child with mild mental retardation. Am J Hum Genet 1997; 60: 113–120.
Bonaglia MC, Giorda R, Borgatti R et al: Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome. Am J Hum Genet 2001; 69: 261–268.
Durand CM, Betancur C, Boeckers TM et al: Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet 2007; 39: 25–27.
Moessner R, Marshall CR, Sutcliffe JS et al: Contribution of SHANK3 mutations to autism spectrum disorder. Am J Hum Genet 2007; 81: 1289–1297.
Romain DR, Goldsmith J, Cairney H, Columbano-Green LM, Smythe RH, Parfitt RG : Partial monosomy for chromosome 22 in a patient with del(22)(pter----q13.1::q13.33----qter). J Med Genet 1990; 27: 588–589.
Fujita Y, Mochizuki D, Mori Y et al: Girl with accelerated growth, hearing loss, inner ear anomalies, delayed myelination of the brain, and del(22)(q13.1q13.2). Am J Med Genet 2000; 92: 195–199.
Nesslinger NJ, Gorski JL, Kurczynski TW et al: Clinical, cytogenetic, and molecular characterization of seven patients with deletions of chromosome 22q13.3. Am J Hum Genet 1994; 54: 464–472.
McTaggart KE, Budarf ML, Driscoll DA, Emanuel BS, Ferreira P, McDermid HE : Cat eye syndrome chromosome breakpoint clustering: identification of two intervals also associated with 22q11 deletion syndrome breakpoints. Cytogenet Cell Genet 1998; 81: 222–228.
Armour JA, Povey S, Jeremiah S, Jeffreys AJ : Systematic cloning of human minisatellites from ordered array charomid libraries. Genomics 1990; 8: 501–512.
Sambrook J, Russell DW : Molecular Cloning: A Laboratory Manual, 3rd edn. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press, 2001.
Church GM, Gilbert W : Genomic sequencing. Proc Natl Acad Sci USA 1984; 81: 1991–1995.
Yobb TM, Somerville MJ, Willatt L et al: Microduplication and triplication of 22q11.2: a highly variable syndrome. Am J Hum Genet 2005; 76: 865–876.
Cockwell AE, Jacobs PA, Crolla JA : Distribution of the D15Z1 copy number polymorphism. Eur J Hum Genet 2007; 15: 441–445.
Boeckers TM, Winter C, Smalla KH et al: Proline-rich synapse-associated proteins ProSAP1 and ProSAP2 interact with synaptic proteins of the SAPAP/GKAP family. Biochem Biophys Res Commun 1999b; 264: 247–252.
Acknowledgements
We thank Dr Shuwen Huang and Miss Sarah Beal for the array CGH analysis and Dr N Simon Thomas for the genotyping of chromosome 15. We also wish to thank the families for participating in this research and Professor Yukisige Yanagawa and Dr Yasuko Yamanouchi (Teikyo University School of Medicine) for assistance. This study was supported by a grant from the Canadian Institutes of Health Research (HEM).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wilson, H., Crolla, J., Walker, D. et al. Interstitial 22q13 deletions: genes other than SHANK3 have major effects on cognitive and language development. Eur J Hum Genet 16, 1301–1310 (2008). https://doi.org/10.1038/ejhg.2008.107
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ejhg.2008.107
Keywords
This article is cited by
-
Phelan-McDermid syndrome: a classification system after 30Â years of experience
Orphanet Journal of Rare Diseases (2022)
-
Investigation of Genetic Polymorphism in Autism Spectrum Disorder: a Pathogenesis of the Neurodevelopmental Disorder
Advances in Neurodevelopmental Disorders (2022)
-
DNA methylation epi-signature is associated with two molecularly and phenotypically distinct clinical subtypes of Phelan-McDermid syndrome
Clinical Epigenetics (2021)
-
Fraternal twins with Phelan-McDermid syndrome not involving the SHANK3 gene: case report and literature review
BMC Medical Genomics (2020)
-
SHANK proteins: roles at the synapse and in autism spectrum disorder
Nature Reviews Neuroscience (2017)
